Captopril inhibited metamphetamine - induced cardiac mitochondrial damage in hyperthermic condition via modulation of biochemical markers

authors:

avatar Mohammad Shokrzadeh , avatar ehsan zamani , avatar javad mollahasani , avatar Fatemeh Shaki , *

Koomesh: Vol.18, issue 1; 128-137
published online: September 28, 2016
article type: Research Article
received: January 05, 2016
accepted: April 03, 2016

how to cite: Shokrzadeh M, zamani E, mollahasani J, Shaki F. Captopril inhibited metamphetamine - induced cardiac mitochondrial damage in hyperthermic condition via modulation of biochemical markers. koomesh. 2016;18(1):e151154. 

Abstract

Introduction: Methamphetamine (METH) is a known abused drug which could induce cardiotoxicity. Captopril is an angiotensin converting enzyme inhibitor that is used in hypertension therapy and has known antioxidant effects. In this study we evaluated the effect of captopril against METH-induced toxicity in rat heart isolated mitochondria in hyperthermic condition. Materials and Methods: Mitochondrial fractions were isolated from heart of Wistar rat with different centrifuge technique. Then, heart isolated mitochondrial were exposed to METH (LC50, 250µM) and captopril (0, 25, 50, 100, 200, 400 µM) and incubated at 37 and 41 C. After 1 h incubation, mitochondrial damage was assayed by MTT test. Also, oxidative stress markers were measured. Results: Our results showed that METH significantly induced mitochondrial damage that was more pronounced in hyperthermic condition. Increased oxidative stress markers such as lipid peroxidation, reactive oxygen species formation and glutathione oxidation in the heart isolated mitochondria were observed after METH exposure that was more significant at 41 c than 37 C. Captopril significantly inhibited METH–induced oxidative stress in the heart isolated mitochondria. Also, captopril pretreatment significantly improved mitochondrial function. Mitochondrial swelling also increased after METH exposure, but was significantly decreased with captopril pre-treatment. Conclusion: These results suggested that captopril could ameliorate METH-induced oxidative stress and mitochondrial dysfunction especially in hyperthermic condition. Therefore, the effectiveness of this antioxidant should be evaluated for the treatment of METH cardiotoxicity

References

  • 1.

    Pourahmad J, Eskandari MR, Nosrati M, Kobarfard F, Khajeamiri AR. Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition. Eur J Pharmacol 2010; 643: 162-169.

  • 2.

    Piper BJ. A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol Teratol 2007; 29: 288-300.

  • 3.

    Brown JM, Yamamoto BK. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 2003; 99: 45-53.

  • 4.

    Ricaurte GA, Seiden L, Schuster CR. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 1984; 303: 359-364.

  • 5.

    Fleckenstein AE, Wilkins DG, Gibb JW, Hanson GR. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 1997; 283: 281-285.

  • 6.

    Yamamoto BK, Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998; 287: 107-114.

  • 7.

    Wagner G, Carelli R, Jarvis M. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Commun Chem Pathol Pharmacol 1985; 47: 221-228.

  • 8.

    De Vito MJ, Wagner G. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 1989; 28: 1145-1150.

  • 9.

    Hirata H, Ladenheim B, Carlson E, Epstein C, Cadet JL. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 1996; 714: 95-103.

  • 10.

    Chan P, Monte DA, Luo JJ, DeLanney LE, Irwin I, Langston JW. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 1994; 62: 2484-2487.

  • 11.

    GRAHAM DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978; 14: 633-643.

  • 12.

    Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994; 268: 1571-1580.

  • 13.

    Skonieczna M, Kruszewska J, Nowak J, Bicz W. Influence of increased environmental temperature on oxidation processes in rat liver mitochondria. Acta Physiol Pol 1985; 37: 157-167.

  • 14.

    Lepock JR, Cheng K-H, Al-qysi H, Sim I, Koch CJ, Kruuv J. Hyperthermia-induced inhibition of respiration and mitochondrial protein denaturation in CHL cells. Int J Hyperthermia 1987; 3: 123-132.

  • 15.

    Madl J, Allen D. Hyperthermia depletes adenosine triphosphate and decreases glutamate uptake in rat hippocampal slices. Neuroscience 1995; 69: 395-405.

  • 16.

    Volti G, Murabito P, Attaguile G, Rodella L, Astuto M, Di Giacomo C, Gullo A. Antioxidant properties of propofol when oxidative stress sleeps with patients. Excli J 2006; 5: 25-32.

  • 17.

    Kazerani H, Haji MB. Effects of sublingual captopril in immediate treatment of hypertensive crisis. Hamedan Sci J. 2007; 14: 1-5##.

  • 18.

    De Cavanagh E, Fraga C, Ferder L, Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am J Physiol Regul Integr Comp Physiol 1997; 272: R514-R518.

  • 19.

    GhaziKhansari M, MohammadiBardbori A, Hosseini MJ. Using janus green B to study paraquat toxicity in rat liver mitochondria. Ann N Y Acad Sci 2006; 1090: 98-107.

  • 20.

    Mohammadi-Bardbori A, Ghazi-Khansari M. The inhibitory effect of captopril on paraquat toxicity in mitochondria isolated from the rat liver. J Kerman Univ Med Sci 2006; 13: 132-140. (Persian).

  • 21.

    Mattson MP. Mechanisms of neuronal apoptosis and excitotoxicity. Pathogenesis of neurodegenerative disorders: Springer 2001; p: 1-20.

  • 22.

    Shaki F, Hosseini MJ, Ghazi-Khansari M, Pourahmad J. Toxicity of depleted uranium on isolated rat kidney mitochondria. Biochim Biophys Acta 2012; 1820: 1940-1950.

  • 23.

    SHokzadeh M, Alidoust F, Nourian Y, Vaezi N, Mohammadi E, SHaki F. Paper: Protective effects of resveratrol against paraquat-induced mitochondrial dysfunction in brain and lung isolated mitochondria. (Persian).

  • 24.

    Zhang F, Xu Z, Gao J, Xu B, Deng Y. In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol 2008; 26: 232-236.

  • 25.

    Sadegh C, Schreck RP. The spectroscopic determination of aqueous sulfite using Ellmans reagent. MURJ 2003; 8: 39-43.

  • 26.

    Hosseini M-J, Shaki F, Ghazi-Khansari M, Pourahmad J. Toxicity of arsenic (III) on isolated liver mitochondria: a new mechanistic approach. Iran J Pharm Res 2013; 12: 121. (Persian).

  • 27.

    Zhao Y, Ye L, Liu H, Xia Q, Zhang Y, Yang X, Wang K. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. J Inorg Biochem 2010; 104: 371-378.

  • 28.

    Miyazaki I. Dopaminergic neuron-specific oxidative stress caused by dopamine itself: Okayama University; 1999.

  • 29.

    Zhang X, Banerjee A, Banks WA, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009; 1275: 87-95.

  • 30.

    Lee YW, Hennig B, Yao J, Toborek M. Methamphetamine induces AP1 and NFB binding and transactivation in human brain endothelial cells. J Neurosci Res 2001; 66: 583-591.

  • 31.

    Halliwell B, Gutteridge J. Free radicals in biology and medicine. NY: Oxford University Press1999968 2011.

  • 32.

    Young TA, Cunningham CC, Bailey SM. Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: studies using myxothiazol. Arch Biochem Biophys 2002; 405: 65-72.

  • 33.

    Hosseini MJ, Shaki F, Ghazi-Khansari M, Pourahmad J. Toxicity of vanadium on isolated rat liver mitochondria: a new mechanistic approach. Metallomics 2013; 5: 152-166.

  • 34.

    Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000; 899: 191-208.

  • 35.

    Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.

  • 36.

    Fiala M, Liu Q, Sayre J, Pop V, Brahmandam V, Graves M, Vinters H. Cyclooxygenase2positive macrophages infiltrate the Alzheimers disease brain and damage the bloodbrain barrier. Eur J Clin Invest 2002; 32: 360-371.

  • 37.

    Parving H-H, Lehnert H, Brchner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N E J Med 2001; 345: 870-878.

  • 38.

    Dineley KE, Richards LL, Votyakova TV, Reynolds IJ. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion 2005; 5: 55-65.

  • 39.

    Ghazi-Khansari M, Mohammadi-bardbori A. Captopril ameliorated mitochondrial toxicity due to paraquat. Toxicol In Vitro 2006; 21: 403-407.

  • 40.

    Patel SP, Katyare SS. Effect of alloxan-diabetes and subsequent treatment with insulin on lipid/phospholipid composition of rat brain microsomes and mitochondria. Neurosci Lett 2006; 399: 129-134.

  • 41.

    Zhong Q, Putt DA, Xu F, Lash LH. Hepatic mitochondrial transport of glutathione: studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells. Arch Biochem Biophys 2008; 474: 119-127.

  • 42.

    Kowaltowski AJ, Netto LE, Vercesi AE. The Thiol-specific antioxidant enzyme prevents mitochondrial permeability transition evidence for the participation of reactive oxygen species in this mechanism. J Biol Chem 1998; 273: 12766-12769.##.